Successful completion of a clinical trial is dependent among many factors which include the appropriate selection of a study population and dose, study design, and individual subject's perceptions about participation. Salient points in the design and conduct of early clinical trials for the development of hypothetical oral cephalosporin antibiotic are discussed.
SpilkerB ed. Guide to clinical studies and developing protocols. New York: Raven Press; 1985.
2.
SpectorR ed. Drug metabolism and pharmacogenetics. In: The scientific basis of clinical pharmacology. Principles and examples. Chap 5. Boston: Little, Brown and Company; 1986: 55–65.
3.
HunninghakeDBDarbyCAProbtsfieldJL. Recruitment in clinical trials: Literature summary and annotated bibliography. Control Clin Trials1987:8: 6S–30S.
4.
WoodAJJOatesJA. Adverse reactions to drugs. In: PetersdorfRG (ed). Harrison's principles of internal medicine. Chap 72. Tenth edn.New York: McGraw-Hill; 1983: 402–409.
5.
HenthornTKBenitezJAvramMJ. Assessment of the debrisoquin and dextromethorphan phenotyping tests by guassian mixture distributions analysis. Clin Pharmacol Ther. 1989:45: 328–333.
6.
DrusanoGL. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988:32: 289–297.
7.
WoodsJRWilliamsJGTavelM. The two-period crossover design in medical research. Ann Intern Med. 1989:110: 560–566.
8.
KramerMSShapiroSH. Scientific challenges in the application of randomized trials. JAMA1984:252: 2739–2745.
